Home › Triple-Negative Breast Cancer › New York › Queens

Pag-aaral pangklinika para sa Triple-Negative Breast Cancer sa Queens, NY

Isang pag-aaral para sa Triple-Negative Breast Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Queens. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

START New York Long Island LLC, Lake Success · 9 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06270706

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

Nagre-recruitPhase 1

NYU Langone Hospital - Long Island, Mineola · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05422794

Study of AVZO-021 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Avenzo Therapeutics Recruiting Site, Mineola · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05867251

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Nagre-recruitPhase 3

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0073), Mineola · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Nagre-recruitPhase 3

Clinical Research Alliance ( Site 0086), Westbury · 14 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06393374

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

Nagre-recruitPhase 1

Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06246968

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Nagre-recruitPhase 2

Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05570253

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Nagre-recruitPhase 3

Northwell Health, Lake Success · 9 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05633654

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Nagre-recruitPhase 1

NYU Langone Health - Long Island, Mineola · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06400472

A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

Nagre-recruitPhase 2

Memorial Sloan Kettering at Nassau (Limited Protocol Activities), Uniondale · 13 mi ang layo

Edad 70 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07768436

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Nagre-recruitPhase 2/3

Clinical Research Alliance, Westbury · 14 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06926868

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Nagre-recruitPhase 1

START New York Long Island, LLC, Lake Success · 9 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT07503808

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Nagre-recruitPhase 2

Memorial Sloan Kettering Nassau, Uniondale · 13 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT03808337

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

Nagre-recruitPhase 2

Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Peb 17, 2026 · NCT04683679

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Nagre-recruitPhase 2

Clinical Research Alliance, Westbury · 14 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 19, 2025 · NCT06568692

Pag-aaral para sa Triple-Negative Breast Cancer sa ibang lungsod

Iba pang pag-aaral sa Queens

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.